Article PDF
Avoid common mistakes on your manuscript.
References
Apriletti JW, David-Inouye Y, Baxter JD, Eberhardt N. Physico-chemical characterization of the intranuclear thyroid hormone receptor. In: Oppenheimer JH, Samuels HH, eds. Molecular Basis of Thyroid Hormone Action. New York, Academic Press, 67–97;1983.
Barker SB, Klitgaard HM. Metabolism of tissues excised from thyroxine-injected rats. Am J Physiol 170:81–93;1952.
Bhat MK, Ashizawa K, Cheng SY. Phosphorylation enhances the target gene sequence-dependent dimerization of thyroid hormones receptor with retinoid X receptor. Proc Natl Acad Sci USA 91:7927–7931;1994.
Bhat MK, Parkison C, McPhie P, Liang CM, Cheng SY. Conformational changes of human β1 thyroid hormone receptor induced by binding of 3,3′,5-triiodo-L-thyronine. Biochem Biophys Res Commun 195:385–392;1993.
Casanova J, Horowitz ZD, Copp RP, McIntyre WR, Pascual A, Samuels HH. Photoaffinity labeling of thyroid hormone nuclear receptors: Influence of n-butyrate and analysis of the halflives of the 57,000 and 47,000 molecular weight receptor forms. J Biol Chem 259:12084–12091;1984.
Cheng SY. Interaction of thyroid hormone with cytosol proteins. In: Wu SY, ed. Thyroid Hormone Metabolism: Regulation and Clinical Implications. Boston, Blackwell Scientific, 145–166;1991.
Cheng SY, Gong QH, Parkison C, Robinson EA, Appella E, Merlino GT, Pastan I. The nucleotide sequence of a human cellular thyroid hormone binding protein present in endoplasmic reticulum. J Biol Chem 262:11221–11227;1987.
Cheng SY, Ransom SC, McPhie P, Bhat MK, Mixson AJ, Weintraub BD. Analysis of the binding of 3,3′,5-triiodo-L-thyronine and its analogues to mutant human β1 thyroid hormone receptors: A model of the hormone binding site. Biochemistry 33:4319–4326;1994.
Chopra IJ. New insights into thyroid hormone deiodination. In: Wu SY, ed. Thyroid Hormone Metabolism, Regulation, and Clinical Implications. Boston, Blackwell Scientific, 41–54;1991.
Chou PY, Fasman GD. Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol 47:45–148;1978.
Cook CB, Kakacska I, Lechan RM, Koenig RJ. Expression of thyroid hormone receptor β2 in rat hypothalamus. Endocrinology 130:1077–1079;1992.
Damm K. c-erbA and retinoic acid receptor gene regulation. In: 4th International Thyroid Symposium: Genetic Aspects of Thyroid and Steroid Hormone Receptors, Molecular Basis and Clinical Expression; 1993.
Falcone M, Miyamoto T, Vierro-Renoy F, Macchia E, DeGroot LJ. Evaluation of the ontogeny of thyroid hormone receptor isotypes in rat brain and liver using an immunohistochemical technique. Eur J Endocrinol 130:97–106;1994.
Farber GG, Petsko GA. The evolution of α/β barrel enzymes. Trends Biochem Sci 15:228–234;1990.
Ford DH, Cramer EB. Developing nervous system in relation to thyroid hormones. In: Grave GD, ed. Thyroid Hormones and Brain Development. New York, Raven, 1–18;1977.
Garnier J, Osguthorpe DJ, Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol 120:97–120;1978.
Glass CK, Holloway JM. Regulation of gene expression by the thyroid hormone receptor. Biochem Biophys Acta 1032:157–176;1990.
Glineur C, Bailly M, Ghysdael J. The c-erbA α-encoded thyroid hormone receptor is phosphorylated in its amino terminal domain by casein kinase II. Oncogene 4:1247–1254;1989.
Goldberg Y, Glineur C, Gesquiere JC, Ricouart A, Sap J, Vennstrom B, Ghysdael J. Activation of protein kinase C or cAMP-dependent protein kinase increases phosphorylation of the c-erbA-encoded thyroid hormone receptor and the v-erbA-encoded protein. EMBO J 7:2425–2433;1988.
Goldfine ID, Simons CG, Smith GJ, Ingbar SH. Cycloleucine transport in isolated rat thymocytes: In vitro effects of triiodothyronine and thyroxine. Endocrinology 96:1030–1137;1975.
Goldfine ID, Smith GJ, Simons CG, Ingbar SH, Jorgensen EC. Activities of thyroid hormones and related compounds in an in vitro thymocyte assay. J Biol Chem 251:4233–4238;1976.
Green S, Chambon P. A superfamily of potentially oncogenic hormone receptors. Nature 324:615–617;1990.
Gross J, Pitt-Rivers R. The identification of 3:5:3'-L-triiodothyronine in human plasma. Lancet 262:439–441;1952.
Gross J, Pitt-Rivers R. 3:5:3'-triiodothyronine. 1: Isolation from thyroid gland and synthesis. Biochem J 53:645–652;1953.
Gross J, Pitt-Rivers R. 3:5:3'-triiodothyronine. 2: Physiological activity. Biochem J 53:652–657;1953.
Harrington CR. Chemistry of thyroxine. I: Isolation of thyroxine from the thyroid gland. Biochem J 20:293–298;1926.
Hoch FL. Metabolic effects of thyroid hormones. In: Greer MA, Solomon DH, ed. Handbook of Physiology, Section 7, Vol 3: The Thyroid. Washington, American Physiological Society, 391–411;1974.
Hodin RA, Lazar MA, Wintman BI, Darling DS, Koenig RJ, Larsen PR, Moore DD, Chin WW. Identification of a thyroid hormone receptor that is pituitary-specific. Science 244:76–79;1989.
Ichikawa K, DeGroot LJ. Purification and characterization of rat liver nuclear thyroid hormone receptor. Proc Natl Acad Sci USA 84:3420–3424;1987.
Ichikawa K, DeGroot LJ. Separation of DNA binding domain from hormone and core histone binding domains by trypsin digestion of rat liver nuclear thyroid hormone receptor. J Biol Chem 15:16540–16546;1986.
Jones KE, Brubaker JH, Chin WW. Evidence that phosphorylation events participate in thyroid hormone action. Endocrinology 134:543–548;1994.
Jorgensen EC. Structure activity relationships of thyroxine analogs. In: Hershmann JM, Bray GA, eds. The Thyroid. Physiology and Treatment of Disease. Oxford, Pergamon, 559–585;1979.
Kurokawa R, Yu VC, Naar A, Kyakumoto S, Han Z, Silverman S, Rosenfeld MG, Glass CK. Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev 7:1423–1435;1993.
Lavin TM. Mechanisms of action of thyroid hormone. In: DeGroot LJ, ed. Endocrinology V. 1. Philadelphia, Saunders, 562–573;1989.
Lazar MA. Thyroid hormone receptors: Multiple forms, multiple possibilities. Endocr Rev 14:184–193;1993.
Lebel JM, Dussault JH, Puymirat J. Overexpression of the β1 thyroid receptor induces differentiation in neuro-2a cells. Proc Natl Acad Sci USA 91:2644–2648;1994.
Lechan RM, Qi Y, Berrodin TJ, Davis KD, Schwartz HL, Strait KA, Oppenheimer JH, Lazar MA. Immunocytochemical delineation of thyroid hormone receptor β2-like immunoreactivity in the rat central nervous system. Endocrinology 132:2461–2469;1993.
Lin KH, Parkison C, McPhie P, Cheng SY. An essential role of domain D in the hormone-binding activity of human β1 thyroid hormone nuclear receptor. Mol Endocrinol 5:485–492;1991.
Lin KH, Willingham MC, Liang CM, Cheng SY. Intracellular distribution of the endogenous and transfected β form of thyroid hormone nuclear receptor visualized by the use of domain-specific monoclonal antibodies. Endocrinology 128:2601–2609;1991.
Lin KH, Ashizawa K, Cheng SY. Phosphorylation stimulates the transcriptional activity of the human β1 thyroid hormone nuclear receptor. Proc Natl Acad Sci USA 89:7737–7741;1992.
Lin KH, Lin YW, Parkison C, Cheng SY. Stimulation of proliferation by 3,3′,5-triiodo-L-thyronine in poorly differentiated human hepatocarcinoma cells overexpressing β1 thyroid hormone receptor. Cancer Lett 85:189–194;1994.
Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR, Sigler PB. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352:497–505;1991.
McGrath ME, Wagner RL, Apriletti JW, West BL, Ramalingam V, Baxter JD, Fletterick RJ. Preliminary crystallographic studies of the ligand-binding domain of the thyroid hormone receptor complexed with triiodothyronine. J Mol Biol 237:236–239;1994.
McPhie P, Parkison C, Lee BK, Cheng SY. Structure of the hormone binding domain of human β1 thyroid hormone nuclear receptor: Is it an α/β barrel? Biochemistry 32:7460–7465;1993.
Maxfield FR, Willingham MC, Pastan I, Dragsten P, Cheng SY. Binding and mobility of the cell surface receptors for 3,3′,5-triiodo-L-thyronine. Science 211:63–65;1981.
Meier CA, Parkison C, Chen A, Ashizawa K, Muchmore P, Meier-Hensler SC, Cheng SY, Weintraub BD. Interaction of human β1 thyroid hormone receptor and its mutants with DNA and RXRβ: T3 response element-dependent dominant negative potency. J Clin Invest 92:1986–1993;1993.
Mitsuhashi T, Tennyson GE, Nikodem VM. Alternative splicing generates messages encoding rat c-erbA proteins that do not bind thyroid hormone. Proc Natl Acad Sci USA 85:5804–5808;1988.
Murray GR. Note on the treatment of myxoedema by hypodermic injection of an extract of the thyroid gland of a sheep. Br Med J ii:796–799;1891.
Nakai A, Seino S, Sakurai A, Szilak I, Bell GI, DeGroot LJ. Characterization of a thyroid hormone receptor expressed in human kidney and other tissues. Proc Natl Acad Sci USA 85:2781–2785;1988.
Nikodem VM, Petty KJ, Mitsuhashi T, Desvergn B. Structure and mechanism of action of thyroid hormone receptors. In: Greer MA, ed. The Thyroid Gland: Comprehensive Endocrinology, New York, Raven, 307–321;1990.
Oatley S, Blake C, Burridge B, De la Paz P. Multiple modes of a binding of thyroid hormone and other iodothyronines to human plasma transthyretin. In: Horn AS, Ranter CJ, eds. X-Ray Crystallography of Drug Action. Oxford, Clarendon, 118–172;1984.
Oppenheimer JH. Thyroid hormone action at the mutation level. In: Braveman LE, Utiger RD, eds. The Thyroid: A Fundamental and Clinical Text. Philadelphia, Lippincott, 204–256;1991.
Oppenheimer JH, Koerner D, Schwartz HL, Surks MI. Specific nuclear triiodothyronine binding sites in rat liver and kidney. J Clin Endocrinol Metab 35:330–333;1972.
Oppenheimer JH, Schwartz HL, Strait KA. Thyroid hormone action 1994: The plot thickens. Eur J Endocrinol 130:15–24;1994.
Oppenheimer JH, Schwartz HL, Surks MI. Tissue differences in the concentration of triiodothyronine nuclear binding sites in the rat: Liver, kidney, pituitary, heart, brain, spleen, and testis. Endocrinology 95:897–903;1974.
Oppenheimer JH, Schwartz HL, Surks MI. Nuclear binding capacity appears to limit the hepatic response toL-triiodothyronine (T3). Endocrinol Res Commun 2:309–325;1975.
Ord WM. On myxoedema, a term proposed to be applied to an essential condition in the ‘cretinoid’ affection occasionally observed in middle-aged women. Med Chir Trans 61:57–59;1878.
Park JB, Ashizawa K, Parkison C, Cheng SY. One-step immunoaffinity of human β1 thyroid hormone receptor with DNA and hormone binding activity. J Biochem Biophys Methods 27:95–103;1993.
Pascual A, Casanova J, Samuels HH. Photoaffinity labeling of thyroid hormone nuclear receptors in intact cells. J Biol Chem 257:9640–9647;1982.
Perlmann T, Rangarajan PN, Umesono K, Evans RM. Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev 7:1411–1422;1993.
Pfahl M, Zhang XH. Regulation of retinoid and thyroid hormone action through homodimeric and heterodimeric receptors. TEM 4:156–162;1993.
Rodd C, Schwartz HL, Strait KA, Oppenheimer JH. Ontogeny of hepatic nuclear triiodothyronine receptor isoforms in the rat. Endocrinology 131:2559–2564;1992.
Samuels HH, Forman BM, Horowitz ZD, Ye ZS. Regulation of gene expression by thyroid hormone. J Clin Invest 81:957–967;1988.
Sap J, Munoz A, Damm K, Goldberg Y, Ghysdael J, Leutz A, Beug H, Vennstrom B. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 324:635–640;1986.
Schräder M, Becker-Andre M, Carlberg C. Thyroid hormone receptor functions as monomeric ligand-induced transcription factor in octameric half sites. J Biol Chem 269:6444–6449;1994.
Schräder M, Müller KM, Carlberg C. Specificity and flexibility of vitamin D signaling: Modulation of the activation of natural vitamin D response elements by thyroid hormone. J Biol Chem 269:5501–5504;1994.
Schräder M, Müller KM, Nayeri S, Kahlen JP, Carbérg C. Vitamin D3-thyroid hormone receptor heterodimer polarity directs ligand sensitivity of transactivation. Nature 370:382–386;1994.
Schwabe JW, Chapman L, Finch JT, Rhodes D. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: How receptors discriminate between their response elements. Cell 75:567–578;1993.
Schwartz HL, Carlson D, Strait KA, Ling NC, Oppenheimer JH. Presence of a T3-binding protein in nuclei of adult rat brain, liver, kidney and heart which interacts with an antiserum to the thyroid hormone receptor β2 isoform. Clin Res 41:130A;1993.
Schwartz HL, Strait KA, Oppenheimer JH. Molecular mechanisms of thyroid hormone action: A physiological perspective. Clin Lab Med 13:543–561;1993.
Segal J, Ingbar SH. Stimulation of α-deoxy-D-glucose uptake in rat thymocytes in vitro by physiological concentrations of triiodothyronine, insulin, or epinephrine. Endocrinology 107:1354–1358;1980.
Segal J, Ingbar SH. An immediate increase in calcium accumulation by rat thymocytes induced by triiodothyronine. Its role in the subsequent metabolic responses. Endocrinology 115:160–166;1984.
Shi YB. Molecular biology of amphibian metamorphosis: A new approach to an old problem. TEM 5:14–20;1994.
Showers MO, Darling DS, Kieffer GD, Chin WW. Isolation and characterization of a cDNA encoding a chicken beta thyroid hormone receptor. DNA Cell Biol 10:211–221;1991.
Sibylle C, Meier Hensler SC, Zhu X, Pernon A, Juge-Aubrey C, Burger A, Cheng SY, Meier CA. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbAα2 and peroxisome proliferator-activated receptor: Evidence for different mechanisms of inhibition. Mol Cell Endocrinol; in press.
Sterling K. Thyroid hormone action: Identification of the mitochondrial thyroid hormone receptor as adenine nucleotide translocase. Thyroid 1:167–171;1991.
Strait KA, Schwartz HI, Oppenheimer JH, Ling NC. Immunoprecipitation of T3-binding protein in rat tissue nuclear extracts by specifically directed antisera. J Biol Chem 267:11794–11799;1992.
Strait KA, Schwartz HL, Perez-Castillo A, Oppenheimer JH. Relationship of c-erbA mRNA content to tissue triiodothyronine nuclear binding capacity and function in developing and adult rats. J Biol Chem 265:10514–10521;1990.
Sugawara A, Yen PM, Apriletti JW, Riberiro RC, Sacks DV, Baxter JD, Chin WW. Phosphorylation selectively increases triiodothyronine receptor homodimer binding to DNA. J Biol Chem 269:433–437;1994.
Sugawara A, Yen PM, Darling DS, Chin WW. Characterization and tissue expression of multiple triiodothyronine receptor-auxiliary proteins and their relationship to the retinoid X-receptors. Endocrinology 133:965–971;1993.
Terry CJ, Blake CC. Comparison of the modeled thyroxine binding site in TBG with experimentally determined site in transthyretin. Protein Eng 5:505–510;1992.
Wahlstrom GM, Sjoberg M, Andersson M, Nordstrom K, Vennstrom B. Binding characteristics of the thyroid hormone receptor homo- and heterodimers to consensus AGGTCA repeat motifs. Mol Endocrinol 6:1013–1022;1992.
Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM. The c-erb-A gene encodes a thyroid hormone receptor. Nature 324:641–646;1986.
Werner SC. History of the thyroid. In: Braverman LE, Utiger RD, eds. The Thyroid: A Fundamental and Clinical Text, ed 6. Philadelphia, Lippincott, 3–6;1991.
Yaoita Y, Shi YB, Brown DD.Xenopus laevis α and β thyroid hormone receptors. Proc Natl Acad Sci USA 87:7090–7094;1990.
Zhang XK, Hoffmann B, Tran PB, Graupner G, Pfahl M. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355:441–446;1992.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cheng, Sy. New insights into the structure and function of the thyroid hormone receptor. J Biomed Sci 2, 77–89 (1995). https://doi.org/10.1007/BF02253060
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02253060